2-Amino-2-methyl-propionitrile hydrochloride, 95.0%, 100g

2-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid, 97.0%, 250mg

5-Bromo-7-fluoro-3,4-dihydronaphthalen-1(2H)-one, 95.0%, 100mg

9,9-Di-n-octylfluorene>97.0%(HPLC)5g

(5S)-5-Phenylpyrrolidin-2-one, 97%, 250mg

2-Bromomethyl-1,3-dioxolane, 95.0%, 100g

2-Amino-6-phenyl-4,5,6,7-tetrahydrobenzo[b]-thiophene-3-carboxylic acid methyl ester, 95.0%, 100mg

2-Nitro-4-(trifluoromethyl)benzyl bromide, 97.0%, 5g

N-(2,4-Dibromophenyl)-N-methyl-2,4-dinitro-6-(trifluoromethyl)aniline, 97%, 100mg

3-Methyl-4-oxo-4,5,6,7-tetrahydro-benzofuran-2-carboxylic acid methyl ester, 95.0%, 500mg

anti-Keratin Type II mouse monoclonal, Ks pan1-8, 0.2 ml

1,3-Thiazol-2-ylmethylamine, 97.0%, 5g

3-Methyl-2-(piperidin-3-yloxy)pyridine hydrochloride, 250mg